A medical article from 1977 that defended the safety of cosmetic talc has now been retracted, and that matters for more than historical reasons. On March 25, 2026, The Lancet retracted its unsigned 1977 commentary on cosmetic talc after evidence showed the piece had been written by Francis J.C. Roe, a paid Johnson & Johnson consultant, and that he shared a draft with the company before publication. The journal said that undisclosed conflict was a clear breach of publishing ethics and that the commentary would not have been published had the editors known about it at the time.
For families dealing with mesothelioma or other illnesses tied to asbestos exposure, this is not just old news being cleaned up. It raises serious questions about how industry-linked science may have shaped public understanding of talc safety for decades. It also shows why careful review of the historical record still matters in asbestos and talc cases today.
At Bailey Cowan Heckaman, we have a dedicated mesothelioma team focused on investigating asbestos exposure and helping victims and families understand their legal options.
What Was the 1977 Article?
The original commentary, published on June 25, 1977, was titled “Cosmetic Talc Powder.” It argued there was no reason to believe normal consumer exposure to cosmetic talc had caused cancer or measurable lung harm. That article carried weight because it appeared in one of the world’s best-known medical journals.
But the story did not end there. According to Columbia Mailman School of Public Health, historians Gerald Markowitz and David Rosner found records showing that the unsigned commentary was not written by The Lancet editors. Instead, they say it was written by Roe, who was being paid as a consultant by Johnson & Johnson, one of the world’s leading producers of cosmetic talc products at the time. They also found evidence that he shared an advance draft with the company and revised it based on company feedback.
That is the kind of fact that can change how a publication is viewed. A piece presented as neutral editorial commentary carries a very different meaning if it was actually shaped by someone with an undisclosed financial tie to a company that stood to benefit from the article’s conclusions.
Why The Retraction Matters
A retraction does not erase the article’s influence. For years, old publications like this one could be cited in public debate, regulatory discussions, and litigation. Columbia’s report says the 1977 commentary played a role in helping stave off federal regulation of asbestos in cosmetic talc in the 1970s and later appeared in litigation over diseases tied to talc exposure.
That is why this retraction matters now. It is not only about one article. It is about whether the public, regulators, courts, and families had the full truth when claims about talc safety were being made.
Talc, Asbestos, and Ongoing Safety Concerns
Talc and asbestos are different minerals, but talc deposits can occur near asbestos in the earth. That is one reason contamination has been such a major concern. In December 2024, the FDA announced a proposed rule to establish standardized testing methods to detect and identify asbestos in talc-containing cosmetic products. The agency said the proposal was intended to help protect users of talc-containing cosmetics from harmful exposure to asbestos.
That point matters because it shows the issue is not academic. Regulators are still dealing with how talc products should be tested for asbestos contamination. When federal agencies are working on testing standards today, a 1977 article downplaying the risks does not belong on a pedestal, especially once hidden conflicts come to light.
Medical literature has also continued to examine talc and cancer risk. In 2024, The Lancet Oncology noted that industry standards used to assess talc-based cosmetic and pharmaceutical products have often been insufficiently sensitive to rule out asbestos contamination.
Johnson & Johnson and the Larger Talc Story
Johnson & Johnson has long denied that its talc products were unsafe, but it also announced in 2022 that it would discontinue talc-based Johnson’s Baby Powder globally in 2023 and move to an all-cornstarch-based portfolio. The company described that as a commercial decision made as part of a worldwide portfolio assessment.
Even so, the retraction puts new focus on how talc safety was discussed in past decades. Bloomberg reported that the 1977 paper had fueled tens of thousands of lawsuits after talc products were linked to cancer allegations. That does not mean every claim is the same, and it does not decide any individual case by itself. But it does show why the integrity of published science matters so much in product exposure cases.
When a respected journal later says a commentary should not have been published because of a hidden conflict, families have every reason to ask hard questions about what they were told, who shaped that message, and whether important warnings were delayed.
What This Could Mean for Families
For victims and families, one of the hardest parts of asbestos-related illness is that the exposure may have happened years or even decades earlier and they may not know there was a connection until after the death of a loved one. Symptoms can appear 20 to 50 years after exposure. By the time a family starts looking for answers, records may be old, witnesses may be gone, and the path of exposure may not be obvious.
That is why historical evidence matters. Old company records, old product information, old medical commentary, and old internal communications can all help tell the real story. The retraction of the 1977 talc safety article is one more reminder that the first version of the story is not always the full one.
How Bailey Cowan Heckaman May Be Able to Help
At Bailey Cowan Heckaman, we know that asbestos and mesothelioma cases are about people, not headlines. Families dealing with a diagnosis are often scared, angry, and overwhelmed. They deserve straight answers about what may have happened and what options may be available.
Our team has a dedicated mesothelioma division that investigates where exposure happened, how it happened, and which companies may be responsible. We represent victims and families in asbestos exposure matters and work to uncover the facts that may have been buried for years.
If you or a loved one is facing mesothelioma after possible asbestos exposure, call Bailey Cowan Heckaman at (713) 425-7100 or reach out online to learn more about your options.
